Review updates clinical management of testicular tumors in dogs

Version 1

A new review in Animals pulls together the current clinical playbook for managing testicular tumors in dogs, underscoring that these are the most common tumors of the male reproductive tract in intact dogs and that most cases fall into three groups: seminomas, Leydig cell tumors, and Sertoli cell tumors. The paper emphasizes that clinical concern is often driven less by metastatic behavior than by hormone activity, especially hyperestrogenism, and it reinforces orchiectomy as the standard treatment in most patients. The authors also note that unilateral orchiectomy can be considered in selected cases when the opposite testis appears normal and preserving fertility or working function still matters. (mdpi.com)

Why it matters: For veterinary professionals, the review is a useful reminder that a scrotal or retained testicle mass isn't just a local surgical problem. Sertoli cell tumors, in particular, can be linked to feminization, alopecia, and even bone marrow suppression through estrogen excess, and cryptorchid dogs carry higher tumor risk than dogs with normally descended testes. The article also highlights practical diagnostic clues, including tumor classification, imaging, hormone assessment, and the role of preputial cytology in suspected hyperestrogenism, which may help clinicians work up cases where a mass isn't obvious on exam. (merckvetmanual.com)

What to watch: Expect this review to be cited in future case management discussions around when testis-sparing decision-making is reasonable, and how clinicians monitor endocrine complications before and after surgery. (mdpi.com)